The short version
11 companies supply this market — deep enough that no single failure threatens the supply.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Fulvestrant
Fulvestrant · FULVESTRANT 250 mg/5mL · Injection, Solution · Intramuscular · BluePoint Laboratories
NDC 68001-0484-85 · 2 SYRINGE, GLASS in 1 CARTON / 5 mL in 1 SYRINGE, GLASS · ANDA · View full market →
One drug, every price
The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.
ⓘ How this was built
Data sources
- CMS NADAC (pharmacy acquisition, weekly)
- CMS Part B ASP quarterly payment limits
- CMS Maximum Fair Prices (IRA negotiated, NDC-level)
- Medicare Part D Spending by Drug (data.cms.gov, name-matched)
- VA FSS / Big4 federal contract prices (va.gov, twice monthly)
- ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
- California SB-17 WAC filings (list price, per package)
Method
Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
- Medicare Part B pays (ASP+6%)$5.28per billing unit (25 MG)HCPCS J9395 · Jul 1, 2026
- Part D plans paid (avg)$65.63per dosage unitgross, before rebates — matched by drug name · 2024
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$1,745.15
Reported to Texas DSHS · 2026 annual filing · Blue Point Laboratories
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Medicare Part B (ASP)
Payment limit per 25 MG
$5.277
HCPCS J9395 · Jul 1, 2026 quarter · typically ASP + 6%
Medicaid spend (2025)
$93,536
557 prescriptions paid by Medicaid nationally · all Medicaid spend →
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- analysis · manufacture
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill · avg $691.92 per prescription
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- ANDA210044
- TE code
- AO
- Approval date
- Mar 4, 2019
- Patents / exclusivity
- None on file
Shortage history
- Planned discontinuation — Fulvestrant, Injection, 250 mg per 5mL (NDC 63323-715-05)Aug 14, 2026
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Fulvestrant (Injection, Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Sagent Pharmaceuticals | FULVESTRANT 50 mg/mL | Jul 15, 2026 | Sep 3, 2026 |
| Athenex Pharmaceutical Division, LLC. | FULVESTRANT 50 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Avenacy, Inc. | FULVESTRANT 50 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| BluePoint Laboratories | FULVESTRANT 250 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| Dr.Reddy's Laboratories Inc | FULVESTRANT 50 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Fresenius Kabi USA, LLC | FULVESTRANT 50 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Northstar Rx, LLC, | FULVESTRANT 50 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Xiromed, LLC | FULVESTRANT 50 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Zydus Lifesciences Limited | FULVESTRANT 50 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Zydus Pharmaceuticals USA Inc. | FULVESTRANT 50 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Amneal Pharmaceuticals LLC | FULVESTRANT 250 mg/5mL | Jul 15, 2026 | Aug 31, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Fulvestrant — NDC 68001-0484-85," retrieved September 3, 2026, https://drugdashboards.com/drug/68001048485.
Free to cite with attribution — see how the data is put together.